Neoplasms, Fibrous Tissue: Clinical Trials

96 trials for Neoplasms, Fibrous Tissue, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

55 completed, 16 recruiting, 9 terminated, 8 active not recruiting. 96 Phase 1, 35 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 196Completed 55, Recruiting 16, Terminated 9, Active not recruiting 8, Not yet recruiting 3, Unknown 2, Withdrawn 2, Enrolling by invitation 1
Phase 235Completed 14, Recruiting 9, Terminated 5, Active not recruiting 4, Enrolling by invitation 1, Not yet recruiting 1, Unknown 1

Follow Neoplasms, Fibrous Tissue: new trials by email Literature Review of Neoplasms, Fibrous Tissue trials Research Report on Neoplasms, Fibrous Tissue

Trials (filtered) newest first · largest first

All 96 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SPARK UPS/MFS: Study Of BET Inhibition With ZEN003694 To Potentiate Anti-Tumor Responses With Radiotherapy To Kickstart Abscopal Effect In Metastatic Undifferentiated Pleomorphic Sarcoma (UPS) And Myxofibrosarcoma (MFS).
ZEN003694, Radiation Therapy - Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma
Phase 1 / Phase 2Not yet recruitingM.D. Anderson Cancer Center572027-05-312026-11-18
A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).
ST316 IV - Familial Adenomatous Polyposis (FAP)
Phase 1Not yet recruitingSapience Therapeutics402027-01-042026-08-12
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor
BMS-986504 - Malignant Peripheral Nerve Sheath Tumors, MPNST
Phase 1 / Phase 2RecruitingAnkit Mangla, MD172026-08-012026-08-11
Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
APG-115, Selumetinib - Malignant Peripheral Nerve Sheath Tumor (MPNST), Neurofibromatosis 1 (NF1)
Phase 1 / Phase 2RecruitingAeRang Kim452026-06-012026-07-27
A Study of DEG6498 in Participants With Solid Tumors
DEG6498 - Malignant Neoplasms
Phase 1RecruitingDegron Therapeutics Co.1002025-11-132026-06-30
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma
Phase 1Active not recruitingJonsson Comprehensive Cancer Center302025-08-012026-10-20
Using CICS-1 and SPM-011 and [18F]FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
BNCT, [18F]FBPA - Thoracic Solid Malignant Tumor
Phase 1 / Phase 2Enrolling by invitationStella Pharma Corporation302025-04-102025-11-19
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
OKN4395, Pembrolizumab, Fasting - Solid Tumours, Sarcoma
Phase 1RecruitingEpkin1462025-01-232026-06-11
NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique
ICG administration - Dermatofibrosarcoma Protuberans (DFSP), Skin Squamous Cell Carcinoma
Phase 1Not yet recruitingThe Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College5922024-10-302024-09-24
Safety and Efficacy Study of Collagenase CNT201 Injection for Treatment of Dupuytren's Contracture
[Step1] CNT201 First-dose, [Step1] CNT201 Low-dose, [Step1] CNT201 Intermediate-dose - Dupuytren Contracture, Dupuytren Disease of Finger
Phase 1 / Phase 2RecruitingCONNEXT602024-07-232026-06-12
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Surgical resection, Proton beam radiation therapy, Pazopanib - Adipocytic Neoplasm, Liposarcoma
Phase 1 / Phase 2RecruitingSt. Jude Children's Research Hospital1392024-03-272026-08-03
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Dedifferentiated Liposarcoma, Metastatic Leiomyosarcoma
Phase 1RecruitingNational Cancer Institute (NCI)302024-02-062026-11-16
SPEARHEAD-3 Pediatric Study
Afamitresgene autoleucel - Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST)
Phase 1 / Phase 2RecruitingUSWM CT, LLC202023-09-012026-08-11
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
TNG462, Pembrolizumab - Locally Advanced Solid Tumor
Phase 1 / Phase 2RecruitingTango Therapeutics, Inc.2252023-05-262026-09-08
FOG-001 in Locally Advanced or Metastatic Solid Tumors
FOG-001, mFOLFOX-6, Nivolumab - Cancer, Colorectal Cancer
Phase 1 / Phase 2RecruitingParabilis Medicines, Inc.6192023-05-232026-10-07
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications
BBI-355, Erlotinib, Futibatinib - Triple Negative Breast Cancer (TNBC), High Grade Serous Ovarian Carcinoma
Phase 1TerminatedBoundless Bio, Inc.852023-03-242026-08-19
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Fludarabine, Cyclophosphamide, MESNA - Pediatric Solid Tumor, Osteosarcoma
Phase 1RecruitingSt. Jude Children's Research Hospital482022-07-062026-05-19
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
MRTX1719 - Mesothelioma, Non Small Cell Lung Cancer
Phase 1RecruitingBristol-Myers Squibb3362022-06-092026-09-02
Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
TNG908 - Locally Advanced Solid Tumor
Phase 1 / Phase 2TerminatedTango Therapeutics, Inc.1102022-03-232026-04-15
Medical Imaging and Focused Ultrasound Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)
Harmonic motion imaging guided focused ultrasound (HMIgFUS), Microbubble-mediated Low Intensity Focused Ultrasound (LIFU), Microbubbles - Fibroadenoma, Breast Cancer Stage I
Phase 1RecruitingColumbia University822022-01-192026-08-13

Showing 20 of 96. Sign in to see all of them.

Narrower conditions

Sarcoma (40)  ·  Neurofibrosarcoma (35)  ·  Histiocytoma, Malignant Fibrous (25)  ·  Ovarian Neoplasms (23)  ·  Leiomyosarcoma (21)  ·  Brenner Tumor (19)  ·  Osteosarcoma (19)  ·  Sarcoma, Synovial (18)  ·  Fallopian Tube Neoplasms (17)  ·  Dermatofibrosarcoma (15)  ·  Liposarcoma (15)  ·  Rhabdomyosarcoma (15)  ·  Sarcoma, Ewing (15)  ·  Carcinoma, Ovarian Epithelial (14)  ·  Desmoid Tumors (14)

Broader conditions

Neoplasms by Histologic Type (96)  ·  Neoplasms, Connective Tissue (96)  ·  Neoplasms, Connective and Soft Tissue (95)  ·  Neoplasms (84)  ·  Neoplasms, Glandular and Epithelial (55)  ·  Neoplasms by Site (53)  ·  Neoplasms, Nerve Tissue (49)  ·  Female Urogenital Diseases (41)  ·  Female Urogenital Diseases and Pregnancy Complications (41)  ·  Urogenital Diseases (41)  ·  Nervous System Diseases (40)  ·  Nervous System Neoplasms (39)  ·  Urogenital Neoplasms (39)  ·  Peripheral Nervous System Neoplasms (36)

Interventions

Carboplatin (9)  ·  Paclitaxel (9)  ·  Taxes (6)  ·  Cisplatin (5)  ·  Doxorubicin (5)  ·  Magnetic Resonance Spectroscopy (5)  ·  pembrolizumab (5)  ·  Bevacizumab (4)  ·  Imatinib Mesylate (4)  ·  Nivolumab (4)  ·  Specimen Handling (4)  ·  Topotecan (4)  ·  Cyclophosphamide (3)  ·  Docetaxel (3)  ·  Filgrastim (3)

Sponsors

National Cancer Institute (NCI) (18)  ·  Gynecologic Oncology Group (8)  ·  Mayo Clinic (4)  ·  Fred Hutchinson Cancer Center (3)  ·  AeRang Kim (2)  ·  Eli Lilly and Company (2)  ·  European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Jonsson Comprehensive Cancer Center (2)  ·  Memorial Sloan Kettering Cancer Center (2)  ·  Seattle Children's Hospital (2)  ·  St. Jude Children's Research Hospital (2)  ·  Tango Therapeutics, Inc. (2)  ·  Valerio Therapeutics (2)  ·  AbbVie (1)  ·  Ankit Mangla, MD (1)

Countries

United States (79)  ·  France (9)  ·  Canada (7)  ·  United Kingdom (7)  ·  Australia (6)  ·  Spain (6)  ·  Denmark (5)  ·  Japan (5)  ·  Italy (4)  ·  Germany (3)  ·  South Korea (3)  ·  China (2)  ·  Taiwan (2)  ·  Belgium (1)  ·  Hong Kong (1)

Top investigators

AeRang Kim, MD, PhD (3)  ·  Peter G. Rose, MD (3)  ·  Don Dizon (2)  ·  Evanthia Galanis, MD (2)  ·  Leona A. Holmberg, MD, PhD (2)  ·  Mark Morgan (2)  ·  Aaron H. Wolfson, MD (1)  ·  Aaron R Weiss, DO (1)  ·  Alba Rubio (1)  ·  Albiruni Razak, M.D. (1)  ·  Alice P Chen, M.D. (1)

Results publications

PMID 31401903, PMID 11705489, PMID 12528778, PMID 12957454, PMID 15010069, PMID 15592836, PMID 16412499, PMID 16631245, PMID 16959305, PMID 19088049, PMID 19671873, PMID 20622000, PMID 23382028, PMID 24089446, PMID 25858498, PMID 28341300, PMID 30410720, PMID 31386610, PMID 31708167, PMID 32089640, PMID 32554315, PMID 33203665, PMID 33610319, PMID 33641042, PMID 34321280, PMID 34814185, PMID 35260879, PMID 38579194, PMID 39255444, PMID 39356980, PMID 39756156, PMID 39956770, PMID 41836677, PMID 42874021

NIH funding

U10CA027469 (8), P50CA136393 (2), U10CA180868 (2), 2008 (1), 2015 (1), 2019 (1), 2023 (1), K08CA245181 (1), N01CM00071 (1), N01CM62206 (1), P30CA008748 (1), P30CA014599 (1), P30CA015083 (1), P30CA016087 (1), R01CA136547 (1)